Fulgent Genetics EBITDA 2015-2025 | FLGT

Fulgent Genetics ebitda from 2015 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Fulgent Genetics Annual EBITDA
(Millions of US $)
2024 $-55
2023 $-53
2022 $216
2021 $695
2020 $294
2019 $2
2018 $-3
2017 $-1
2016 $2
2015 $-4
2014 $-1
Fulgent Genetics Quarterly EBITDA
(Millions of US $)
2025-03-31 $-16
2024-12-31 $-11
2024-09-30 $-12
2024-06-30 $-14
2024-03-31 $-16
2023-12-31 $-26
2023-09-30 $5
2023-06-30 $-14
2023-03-31 $-18
2022-12-31 $-26
2022-09-30 $11
2022-06-30 $22
2022-03-31 $209
2021-12-31 $156
2021-09-30 $165
2021-06-30 $103
2021-03-31 $270
2020-12-31 $228
2020-09-30 $64
2020-06-30 $3
2020-03-31 $-1
2019-12-31 $0
2019-09-30 $2
2019-06-30 $1
2019-03-31 $-1
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-1
2017-06-30 $0
2017-03-31 $1
2016-12-31 $2
2016-09-30 $0
2016-06-30 $1
2016-03-31 $0
2015-12-31
2015-09-30 $1
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.630B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.172B 59.16
Hims & Hers Health (HIMS) United States $12.418B 139.02
Tempus AI (TEM) United States $12.340B 0.00
IRhythm Technologies (IRTC) United States $4.592B 0.00
Inspire Medical Systems (INSP) United States $3.751B 59.77
Privia Health (PRVA) United States $2.761B 190.75
Hinge Health (HNGE) United States $2.719B 0.00
Enovis (ENOV) United States $1.822B 10.27
Schrodinger (SDGR) United States $1.572B 0.00
Phreesia (PHR) United States $1.547B 0.00
Clover Health Investments (CLOV) United States $1.468B 0.00
Azenta (AZTA) United States $1.401B 65.30
Omnicell (OMCL) United States $1.370B 24.15
10x Genomics (TXG) United States $1.282B 0.00
Claritev (CTEV) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Talkspace (TALK) United States $0.477B 140.50
Standard BioTools (LAB) United States $0.399B 0.00
Outset Medical (OM) United States $0.354B 0.00
TruBridge (TBRG) United States $0.347B 778.33
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
KORU Medical Systems (KRMD) United States $0.149B 0.00
EUDA Health Holdings (EUDA) Singapore $0.138B 0.00
Pulmonx (LUNG) United States $0.122B 0.00
American Well (AMWL) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.095B 0.00
CareCloud (CCLD) United States $0.088B 3.44
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.051B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00